Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.

Autor: Liu, Jie1,2 (AUTHOR), Yang, Shuo1,2 (AUTHOR), Cao, Bihui3 (AUTHOR), Zhou, Guangyu1,2 (AUTHOR), Zhang, Fengjuan1,2 (AUTHOR), Wang, Yuan1,2 (AUTHOR), Wang, Rixin1,2 (AUTHOR), Zhu, Lipeng1,2 (AUTHOR), Meng, Ya4 (AUTHOR), Hu, Cong4 (AUTHOR), Liang, Hui4 (AUTHOR), Lin, Xu4 (AUTHOR), Zhu, Kangshun3 (AUTHOR), Chen, Guokai1,2 (AUTHOR), Luo, Kathy Qian1,2 (AUTHOR), Di, Lijun1,2 (AUTHOR), Zhao, Qi1,2 (AUTHOR) qizhao@um.edu.mo
Zdroj: Journal of Hematology & Oncology. 1/29/2021, Vol. 14 Issue 1, p1-18. 18p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje